Resistance in the Genes: Why Popular Obesity Drugs Don’t Work for Everyone
GLP-1 receptor agonists like Wegovy and Mounjaro have fundamentally reshaped the treatment of diabetes and obesity.
Search results for "semaglutide"
Sam Chun Dang Pharm Secures Exclusive U.S. Licensing Deal for Oral Obesity and Diabetes Treatment
Sam Chun Dang Pharm has entered into a significant license-out agreement with an undisclosed U.S. partner for the commercialization of oral...
Can Wegovy and Mounjaro Reduce Cancer Risk?
Global obesity experts have proposed a large-scale, long-term follow-up study to verify whether the use of modern...
The Unexpected Heart Benefits of Weight Loss Injections: Reducing Complications After Heart Attack
New research indicates that the class of drugs used in popular weight loss injections may do more than shed pounds;...
"Wegovy is a No": A Comprehensive Look at Olympic Doping and Detection Technology
As the 2026 Milan-Cortina d'Ampezzo Winter Olympics continue, the world of sports is once again focused on the thin...
Does Mounjaro Harm Eye Health? Long-Term Study Shows Diabetic Retinopathy Risk Actually Drops
Concerns that Eli Lilly’s popular weight-loss and diabetes treatment, Mounjaro, might exacerbate eye complications in...
Oral Weight-Loss Pills: Cardiovascular Benefits Beyond Weight Loss
New research suggests that oral semaglutide can reduce the risk of heart failure and major cardiovascular events, even...
High Efficacy and Increased Convenience: The Three Obesity Drugs Awaiting FDA Approval
Since the World Health Organization recommended the use of obesity medications for adults last December, the market is...
'10kg Weight Loss' Pani Bottle, Yo-Yo After Stopping Wegovy
Travel YouTuber Pani Bottle confessed to experiencing a yo-yo effect. Pani Bottle recently posted a photo taken during...
Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?
Denmark's Novo Nordisk's obesity drug ‘Wegovy Pill (ingredient name Semaglutide)’ has recently been launched in the U. S.